Publication Name	World Journal of Gastroenterology
Manuscript ID	81199
Country	South Korea

Received	2022-10-29 10:41
Peer-Review Started	2022-10-29 10:43
To Make the First Decision
Return for Revision	2023-01-03 07:31
Revised	2023-01-13 11:10
Second Decision	2023-03-10 03:18
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-03-14 18:20
Articles in Press	2023-03-14 18:20
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-03-20 09:01
Publish the Manuscript Online	2023-03-28 12:59

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Obesity and novel management of inflammatory bowel disease
Manuscript Source	Invited Manuscript
All Author List	Jee Hyun Kim, Chang-Myung Oh and Jun Hwan Yoo
Funding Agency and Grant Number	Funding Agency Grant Number National Research Foundation of Korea grant from the Korean government, the Ministry of Science and ICT NRF-2020R1F1A1066323, NRF-2021R1F1A1061550
Corresponding Author	Jun Hwan Yoo, MD, PhD, Assistant Professor, Department of Gastroenterology, CHA Bundang Medical Center, CHA University School of Medicine, 59 Yatap-ro, Bundang-gu, Seongnam 13496, South Korea. jhyoo@cha.ac.kr
Key Words	Obesity; Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis
Core Tip	Obesity is prevalent within the inflammatory bowel disease (IBD) population, particularly in newly developed countries. The dysfunction of mesenteric fat worsens the inflammatory course of Crohn’s disease and may induce formation of strictures or fistulas. Furthermore, obesity may affect the disease course or treatment response of IBD. Along with the increasing data that support pathophysiologic and epidemiologic relationship between obesity and IBD, attention is being focused on obesity control as a novel management of IBD. The main purpose of this review is to describe the influence of obesity on the outcomes of IBD treatment and to present the current status of pharmacologic or surgical anti-obesity treatments in IBD patients.
Publish Date	2023-03-28 12:59
Citation	Kim JH, Oh CM, Yoo JH. Obesity and novel management of inflammatory bowel disease. World J Gastroenterol 2023; 29(12): 1779-1794
URL	https://www.wjgnet.com/1007-9327/full/v29/i12/1779.htm
DOI	https://dx.doi.org/10.3748/wjg.v29.i12.1779

Full Article (PDF)	WJG-29-1779.pdf
Full Article (Word)	WJG-29-1779.docx
Manuscript File	81199_Auto_Edited-LM.docx
Answering Reviewers	81199-Answering reviewers.pdf
Audio Core Tip	81199-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	81199-Conflict-of-interest statement.pdf
Copyright License Agreement	81199-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	81199-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	81199-Language certificate.pdf
Peer-review Report	81199-Peer-review(s).pdf
Scientific Misconduct Check	81199-Bing-Wang JJ-2.png
Scientific Editor Work List	81199-Scientific editor work list.pdf